1. Home
  2. DTSS vs MBRX Comparison

DTSS vs MBRX Comparison

Compare DTSS & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$1.10

Market Cap

10.9M

Sector

Technology

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$4.15

Market Cap

12.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTSS
MBRX
Founded
2014
2015
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
12.8M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
DTSS
MBRX
Price
$1.10
$4.15
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$105.50
AVG Volume (30 Days)
129.4K
110.7K
Earning Date
02-11-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$64,349,277.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
68.56
N/A
52 Week Low
$0.64
$3.13
52 Week High
$2.89
$91.25

Technical Indicators

Market Signals
Indicator
DTSS
MBRX
Relative Strength Index (RSI) 51.36 48.33
Support Level $0.82 $3.85
Resistance Level $1.15 $4.39
Average True Range (ATR) 0.17 0.32
MACD -0.00 -0.06
Stochastic Oscillator 33.68 23.79

Price Performance

Historical Comparison
DTSS
MBRX

About DTSS Datasea Inc.

Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Share on Social Networks: